Short Interest in Curative Biotechnology, Inc. (OTCMKTS:CUBT) Expands By 5,800.0%

Curative Biotechnology, Inc. (OTCMKTS:CUBT) was the target of a large growth in short interest in August. As of August 31st, there was short interest totalling 5,900 shares, a growth of 5,800.0% from the August 15th total of 100 shares. Based on an average daily trading volume, of 26,700 shares, the days-to-cover ratio is presently 0.2 days.

Curative Biotechnology Stock Performance

OTCMKTS:CUBT traded up $0.00 during mid-day trading on Thursday, reaching $0.01. The stock had a trading volume of 3,000 shares, compared to its average volume of 191,394. Curative Biotechnology has a one year low of $0.00 and a one year high of $0.04. The firm has a 50 day moving average price of $0.02 and a two-hundred day moving average price of $0.02.

About Curative Biotechnology

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies.